HTAsiaLink is a network of organisational and individual members who are involved in Health Technology Assessment (HTA) research and evidence-based policy decision-making in the Asia Pacific region. Organisational members include HTA institutions, government HTA units, and other relevant organisations. Individual members include researchers, academics, and professionals in the field of HTA.
Since its establishment in 2011 by the three founding members — Health Intervention and Technology Assessment Program (HITAP), National Evidence-Based Healthcare Collaborating Agency (NECA), and Center for Drug Evaluation (CDE) — the network operates continuously with various collaborative research and annual conferences held to bring together members for networking, sharing of research findings, and collaborative discussions.
HTAsiaLink serves as a platform for knowledge transfer and exchange related to evidence-based priority setting, with the main objective of enhancing the capacity for HTA research and promoting the integration of HTA evidence into policy decisions. The network was formed to address the need for strengthening HTA capacity in Asia and promoting the use of HTA evidence in policy decisions.
HTAsiaLink Timeline
Start Collaborations
HITAP, NECA, and CDE started collaborations in 2010. The first meeting took place in Phuket, Thailand on September 4th, 2010, with the active participation of colleagues from Korea, Malaysia, and Thailand, marking the inception of HTAsiaLink.
International Symposium & NECA was the Secretariat (2011–2022)
The network agreed to create an electronic newsletter and initiate a cross-country study on the social value of QALYs in Asia. The first HTAsiaLink newsletter was distributed in June 2011.
1st Annual Conference
The 1st HTAsiaLink Annual Conference with the theme "Economic Evaluation and Health Systems and Policy Research" was held in Cha Am, Phetchaburi, Thailand, in May 2012.
Global Collaboration
HTAsiaLink officially signed a Memorandum of Understanding (MoU) with EuroScan in October 2017, solidifying the commitment to synergistically advance the field of health technology assessment on an international scale.
Memorandum of Understanding for Collaborative HTA & Health Economics Practices in Asia
A Memorandum of Understanding representing collaborative intentions between HTAsiaLink Network, Health Technology Assessment International (HTAi) Society, and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) was signed in 2020.
Formation of Joint Working Collaboration & HITAP was the Secretariat (2022–2025)
Formation of the Joint Working Collaboration between HTAi, HTAsiaLink, and ISPOR-developing a stepwise guide for HTA guideline development. With the strong support of the HTAsiaLink Board and Secretariat, the HTAsiaLink Strategic Plan 2025 –2030 was successfully launched in 2025.
Moving Forward Together: CDE is the Transition Secretariat
Center for Drug Evaluation (CDE) assumes the role of Transition Secretariat, continuing the network’s mission to strengthen coordination and communication across the HTA community in Asia.
For more information, please visit the HTAsiaLink website.